Richard Scheller
American neuroscientist / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Richard Scheller?
Summarize this article for a 10 year old
Richard H. Scheller (born 30 October 1953) is the former Chief Science Officer and Head of Therapeutics at 23andMe and the former Executive Vice President of Research and Early Development at Genentech.[1] He was a professor at Stanford University from 1982 to 2001 before joining Genentech. He has been awarded the Alan T. Waterman Award in 1989, the W. Alden Spencer Award in 1993 and the NAS Award in Molecular Biology in 1997, won the 2010 Kavli Prize in Neuroscience with Thomas C. Südhof and James E. Rothman, and won the 2013 Albert Lasker Award for Basic Medical Research with Thomas Südhof. He was also given the Life Sciences Distinguished Alumni Award from University of Wisconsin–Madison. He is a Fellow of the American Academy of Arts and Sciences and a Member of the National Academy of Sciences.
Richard H. Scheller | |
---|---|
Born | (1953-10-30) October 30, 1953 (age 70) |
Alma mater | University of Wisconsin–Madison, California Institute of Technology, Columbia University |
Known for | Head of gRED |
Awards | NAS Award in Molecular Biology (1997) Kavli Prize (2010) Albert Lasker Award for Basic Medical Research (2013) |
Scientific career | |
Fields | Neuroscience |
Institutions | Genentech, University of California San Francisco |
Doctoral advisor | Eric H. Davidson |
Other academic advisors | Eric Kandel, Richard Axel |